“Smoking Cessation – Data, Analysis & Forecasts to 2023” which also breaks down the market in terms of current smoking cessation drugs and products that occupy the market at present; examining the key prescription and OTC drugs that drive the market.
Pharmaceutical, Commercial & Strategic Developments in the Global Smoking Cessation Market 2013-2023
GMR Data’s new pharmaceutical report outlines the factors affecting the global smoking cessation market across the forecast period 2013-2023. The report outlines key drivers and restraints of the market in all key global geographies.
Drivers include;
Increased health care / health education in many geographies
Adoption of smoking cessation products onto health insurance policies
Increasing number of smoking cessation products emerging onto the market
Emergence of e-cigarettes onto the global market
Over 1bn smokers world wide
This report quantifies the market, in terms of each key geography; explaining which direction each key market will head across the next ten years, and why, with detailed financial forecasts. The report contains over 100 pages as well as 85 charts, graphs and tables detailing the market.
In addition to this crucial information this report offers analysis and opinion on current R&D in the smoking cessation sector alongside in depth analysis of the emerging, global e-cigarette market.
This report also includes 3 original, exclusive, interview transcripts with key global pharmaceutical companies;
Pfizer
Elder Pharmaceuticals
GlaxoSmithKline
Companies
22nd Century Group, Inc
Acrux
Alcon Inc
Altria Group Inc
Alza Corporation
American Lung Association and Cancer Advocacy Coalition of Canada
Aradigm Corporation
Biota Holdings Ltd
Biota Pharmaceuticals, Inc.
Birlaveda
British American Tobacco
Celtic Pharmaceuticals
Cipla
CN Creative
Cytos Biotechnology
Elder Pharmaceuticals limited
EverSmoke Electronic Cigarettes
Evotec AG
Extab Corporation
Frii Inc
GlaxoSmithKline
Green Smoke Inc
Imperial Tobacco
Independent Pharmaceutica AB
Institute of Human Behaviour & Allied Sciences
Invion Limited
Johnson & Johnson
KLOX Technologies
Lorillard Inc
McNeil
Nabi Biopharmaceuticals
NAL Pharmaceuticals
National Institute on Drug Abuse
Nicobrand
Niconovum AB
NJOY
Novartis
Nu Mark LLC
Perrigo
Pfizer Inc
Pure Cigs, LLC
Reynolds American Inc
RML Hospital and Chronic Care Foundation
Sandoz Pharmaceuticals
Selecta Biosciences, Inc
Shanghai Johnson & Johnson Pharmaceutical Ltd
Sopharma
South Beach Smoke
Sun Pharma
Taranabant, Merck & Co
Teva Pharmaceuticals
U.S. Preventive Services Task Force
University of Chicago
Vapor King
Volcano Fine Electronic Cigarettes
Watson Pharmaceuticals
White Cloud Electronic Cigarettes
Table of Contents :
1 Executive Summary
1.1. Smoking Cessation Market Review
1.2. Chapter Breakdown
1.3. Research and Analysis Methods
2 Introduction to Smoking Cessation
2.1. Smoking Cessation Treatment Overview
2.1.1. Nicotine Replacement Therapy (NRT)
2.1.2. Non-NRT Therapy
2.2. Global Tobacco Consumption Prevalence, Trends & Impact
2.2.1. Prevalence of Death Caused due to Tobacco
2.2.2. Second-Hand Smoking
2.2.3. Increased Awareness of Health Implications in Relation to Smoking
2.2.4. Enforcement of Bans on Tobacco Product Advertising & Promotions
2.2.5. Increased Taxation
3 Smoking Cessation Market Forecasts
3.1. Global Smoking Cessation Market
3.1.1. Global Smoking Cessation Market
3.1.2. Global Prescription Drugs Smoking Cessation Market
4 Key Global Smoking Cessation Markets 2013-2023
4.1. The US Smoking Cessation Market – Set to Occupy 45-50% of the Global Market Across 2013-2023
4.2. The UK Smoking Cessation Market – How Will This Mature Market Grow Through 2013-2023?
4.3. The France Smoking Cessation Market – How Much of the Global Smoking Cessation Market Will France Occupy to 2023?
4.4. The German Smoking Cessation Market – Will Reduced German Tobacco Consumption Drive the Smoking Cessation Market?
4.5. The Spanish Smoking Cessation Market – The Strictest Anti-Smoking Laws in the EU, How Will This Affect The Spanish Smoking Cessation Market?
4.6. The Italian Smoking Cessation Market – How Will Strong E-cigarette Sales Affect Other NRT Products in the Italian Smoking Cessation Market?
4.7. The Japanese Smoking Cessation Market – Why Does GMR Data Forecast a Low Growth Rate in the Japanese Smoking Cessation Market?
4.8. The Rest of World Smoking Cessation Market – How Will Emerging Markets, Such as India & China, Affect theGlobal Smoking Cessation Market Across 2013-2023?
5 Nicotine Replacement Therapies (NRT) Market
5.1. NicoDerm CQ
5.2. Nicotrol
5.3. Habitrol (Nicotinell)
5.4. Nicorette
6 Prescription Drugs Smoking Cessation Market
6.1. Chantix (by Pfizer): Varenicline
6.2. Zyban / Wellbutrin (by GSK): bupropion
7 Leading Companies in the Global Smoking Cessation Market
7.1. Pfizer
7.2. GlaxoSmithKline (GSK)
7.3. Novartis
7.4. Johnson & Johnson (J&J)
7.5. Perrigo
7.6. Sophomore and Extab
7.7. 22nd Century Group, Inc.